To this end, the predictive value of various features of tumors, host immune cells and the tumor microenvironment have been further explored including PD-L1 expression in both tumor and immune cells, selected single gene mutational status, peripheral-blood lymphocyte count, tumor infiltrating lymphocyte count, markers of T-cell activation and evaluation of inflammatory cytokines [18]. This evidence concerns the gene CD274 and neoplasm.